Exousia Bio (LMMY) Cash & Current Investments (2022 - 2025)

Exousia Bio (LMMY) has 4 years of Cash & Current Investments data on file, last reported at $1028.0 in Q1 2025.

• Quarterly Cash & Current Investments changed 0.0% year-over-year to $1028.0 in Q1 2025, while the trailing twelve-month figure through Feb 2025 was $1028.0 (changed 0.0% YoY) and the FY2024 annual result came in at $1028.0, down 86.91% from the prior year.
• Cash & Current Investments was little changed at $1028.0 in Q1 2025 per LMMY's latest filing, from $1028.0 in the prior quarter.
• The five-year high for Cash & Current Investments was $10107.0 in Q2 2022, with the low at $1028.0 in Q4 2023.
• Average Cash & Current Investments over 4 years is $2814.8, with a median of $1028.0 recorded in 2023.
• The widest YoY moves for Cash & Current Investments: up 0.0% in 2024, down 86.91% in 2024.
• Exousia Bio's Cash & Current Investments stood at $1351.0 in 2022, then fell by 23.91% to $1028.0 in 2023, then changed by 0.0% to $1028.0 in 2024, then changed by 0.0% to $1028.0 in 2025.
• Business Quant data shows LMMY's Cash & Current Investments at $1028.0 in Q1 2025, $1028.0 in Q4 2024, and $1028.0 in Q3 2024.